Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial

BACKGROUND: There are no effective therapies for patients with coronavirus disease-2019 (COVID-19). METHODS: Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) (n = 23) and control (n = 18). The primary outcome were the tim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Antimicrob Agents
Main Authors: Li, Guoming, Yuan, Mei, Li, Haihong, Deng, Changsheng, Wang, Qi, Tang, Yexiao, Zhang, Hongying, Yu, Weisheng, Xu, Qin, Zou, Yuanyuan, Yuan, Yueming, Guo, Jiawen, Jin, Chunming, Guan, Xiangdong, Xie, Fengjie, Song, Jianping
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605811/
https://ncbi.nlm.nih.gov/pubmed/33152450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106216
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados